SERB Pharmaceuticals

SERB equips healthcare providers worldwide with life-saving medicines for patients facing rare diseases and emergencies.
#emergencymedicine #raredisease #CBRN

[SERB Pharmaceuticals @SERB_Pharma]

We’re excited to share that our CEO, Vanessa Wolfeler, will be at #fiercebiotechweek to present “Commercializing Therapies for Rare and Critical Care Populations.” Wed, May 13 | 03:25 pm–03:50 pm | Picasso 1&2.

Session: https://t.co/SZaHYx0xTQ

#fbw2026 @LifeSciEvents

[SERB Pharmaceuticals @SERB_Pharma]

Last week, we were privileged to attend “A Night of Honor: When the World Stopped, They Stood,” hosted by @NFFF_News during #FDIC2026 in Indianapolis - an evening honoring the fire service’s 9/11 sacrifice.

Thank you, NFFF, for the meaningful event and VIP reception. #ANightOfHonor #FireFighters #InternationalFirefightersDay
GL-CORP-2600025

[NFFF @NFFF_News]

Attending FDIC this month? Join us for A Night of Honor: When the World Stopped, They Stood — an unforgettable evening dedicated to honoring the courage, leadership, and sacrifice of the fire service on the 25th Anniversary of 9/11. https://t.co/1rRdcZnkIa

[SERB Pharmaceuticals @SERB_Pharma]

Thank you to everyone who took the time to visit our booth at the 2026 American Burn Association (ABA) Annual Meeting last week.

We look forward to continuing the conversation and collaborating beyond the conference.

#ABAMeeting2026 #BurnCare #WoundCare @Ameriburn

GL-CORP-2600016

[SERB Pharmaceuticals @SERB_Pharma]

We’re pleased to welcome Vignesh Rajah to SERB as our new Chief Medical Officer; a pivotal role in advancing the company’s scientific and medical capabilities, supporting the launch of new products, deepening engagement with the medical and scientific community, and identifying new opportunities to help patients.
#WelcometotheTeam

https://t.co/7J83L6pumN

[SERB Pharmaceuticals @SERB_Pharma]

News for investors & media:
We're pleased to announce the completion of our acquisition of Y-mAbs Therapeutics, a significant step forward in SERB’s strategy and vision for #Rare #Oncology.

[SERB Pharmaceuticals @SERB_Pharma]

Thank You for connecting with us at #acep25! We truly appreciate all the healthcare professionals who took the time to engage in meaningful discussions about Emergency Medicine.

https://t.co/WjovnxhfYl

[SERB Pharmaceuticals @SERB_Pharma]

Heading to IDN Fall Summit? We’d love to connect! Join us at IDN Fall Summit to explore how SERB is helping drive innovations in Emergency Medicine and Oncology treatments and meet our team.

Let’s shape the future of healthcare together—see you there!

Link: https://t.co/6mZotpB7EA

[SERB Pharmaceuticals @SERB_Pharma]

Healthcare professionals let's connect! Join us at IDN Fall Summit to explore the latest innovations, network with industry leaders, and shape the future of healthcare.

Don’t miss this opportunity to gain insights and collaborate with like-minded professionals. See you there!

Link: https://t.co/6mZotpB7EA

[SERB Pharmaceuticals @SERB_Pharma]

Once again, SERB Pharmaceuticals is extremely proud to be sponsoring #FACTOR2025 !​

We at SERB Pharmaceuticals are privileged to be able to contribute to the mission of the MIB Agents to #MakeItBetter for the #osteosarcoma community. ​

See you there in Salt Lake City ✈️

[SERB Pharmaceuticals @SERB_Pharma]

CBRNe Convergence is back for another year, this time in Poland, bringing together experts in #CBRN defence and #HAZMAT response to discuss current CBRN threats, cutting-edge technology and the future of high intensity CBRN operations. ​

Visit our CBRN team at booth no. 3

[SERB Pharmaceuticals @SERB_Pharma]

Last week the SERB team was in Nebraska for #VenomWeek to explore the latest clinical and scientific developments in the world of venom #toxinology and envenomation.🐍 ​

#VenomWeek2025 #SnakeBiteAwareness

[SERB Pharmaceuticals @SERB_Pharma]

Our 2025 #SERBGlobalChallenge is over! 🌎 For 4 weeks, over 220 of our employees covered a distance of 63,899 km, and avoiding 2,680 kg of CO2.

#SERBGlobalChallenge is just one way we're promoting our values, encouraging employee #wellness and raising #EnvironmentalAwareness.

[SERB Pharmaceuticals @SERB_Pharma]

Join our team at https://t.co/wQJNNlgmM9
#Careers #ProudToSaveLives

[SERB Pharmaceuticals @SERB_Pharma]

The final results of the Phase 3 REVERSE-IT trial were presented today at #ACC25. The study achieved its primary endpoint. Explore the data: https://t.co/fXliWa3482

[SERB Pharmaceuticals @SERB_Pharma]

We are thrilled to announce publication of the largest and most comprehensive study to date of Voraxaze® (glucarpidase)in the peer-reviewed journal Blood, the flagship journal of the American Society of Hematology.

https://t.co/FHfA3JU9lf

[SERB Pharmaceuticals @SERB_Pharma]

We’re pleased to welcome Graeme Steller to the SERB team as our new Director of Corporate Strategy. Graeme will help our teams navigate product commercialization efforts and business development opportunities.
#WelcometotheTeam

[SERB Pharmaceuticals @SERB_Pharma]

We’re pleased to welcome Tim Cope to the SERB team as our new US VP and Cardiology Business Unit leader.  Tim brings a passion for enhancing patient access, launching transformative therapies and cultivating high-performing teams.

#WelcometotheTeam